Background Although coronavirus disease 2019 (COVID-19) is a mild infection in most
children, a small proportion develop severe or critical illness. Data describing agents with …

Understanding the role that children play in the clinical burden and propagation of severe
acute respiratory syndrome coronavirus 2, responsible for coronavirus disease 2019 …

Abstract Background Starting in November 2020, the US Food and Drug Administration
(FDA) has issued Emergency Use Authorizations (EUAs) for multiple novel virus-neutralizing …

Background. We report the first confirmed case of eczema vaccinatum in the United States
related to smallpox vaccination since routine vaccination was discontinued in 1972. A 28 …

Background Although coronavirus disease 2019 (COVID-19) is mild in nearly all children, a
small proportion of pediatric patients develop severe or critical illness. Guidance is therefore …

Background Infectious complications of chimeric antigen receptor (CAR) T-cell
immunotherapy in children and young adults have not been well described. Methods …

Mortality among patients hospitalized for COVID‐19 has declined over the course of the
pandemic. Mortality trends specifically in solid organ transplant recipients (SOTR) are …

Abstract Background In November 2020, the US Food and Drug Administration (FDA)
provided Emergency Use Authorizations (EUA) for 2 novel virus-neutralizing monoclonal …

Background Over the past several decades, there have been advances in diagnosis and
treatment of neonatal herpes simplex virus (HSV) disease. There has been no recent …

Abstract Treatment options for adenovirus infection in immunocompromised children are
limited. Nephrotoxicity has been associated with cidofovir use, but the rate of cidofovir …